Newsroom – Important Announcements and Information Regarding Cosette Pharma

Bridgewater, NJ (November 1, 2019) – Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it will be commercializing Migergot® (ergotamine tartrate and caffeine suppositories) for the US market and will continue its role as the manufacturer. “We are very pleased to be launching Migergot® for several important reasons,” said Walt Kaczmarek, President and Chief Executive Officer of Cosette.  “First, it marks an important milestone as the first product in our portfolio to be marketed in a Cosette label to customers and patients.  Second, it demonstrates our continued commitment to enhancing the Cosette product line with products where we can leverage our expertise in suppositories and other differentiated dosage forms.” Migergot® is [...]

Bridgewater, NJ (October 31, 2019) – Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it has purchased G&W Laboratories’ finished dosage manufacturing plant located in Lincolnton, NC. “The purchase of the Lincolnton plant expands Cosette’s capabilities into new dosage forms while simultaneously allowing us to enter a new business vertical that complements our overall growth strategy,” said Walt Kaczmarek, President and Chief Executive Officer of Cosette.  “The Lincolnton facility has an excellent track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and operates as a contract manufacturer across multiple presentations for select business partners.  We look forward to integrating their expertise and capabilities to the Cosette family and [...]